Gastrointestinal Bleeding From Duodenal Aberrant Pancreas After Antiangiogenic Therapy

J Clin Gastroenterol. 2016 Sep;50(8):689-90. doi: 10.1097/MCG.0000000000000561.

Authors

Koji Nishimoto¹, Masato Karayama, Norimichi Akiyama, Seiichiro Suzuki, Yusuke Inoue, Masato Kono, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Takafumi Suda

Affiliation

¹ Departments of *Internal Medicine Second Division †Clinical Oncology ‡Clinical Pharmacology and Therapeutics Hamamatsu University School of Medicine Hamamatsu, Japan.

PMID: 27306939
DOI: 10.1097/MCG.0000000000000561

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adenocarcinoma / drug therapy
Angiogenesis Inhibitors / adverse effects*
Bevacizumab / adverse effects*
Choristoma / complications*
Duodenal Diseases / complications*
Gastrointestinal Hemorrhage / etiology*
Humans
Lung Neoplasms / drug therapy
Male
Middle Aged
Pancreas*

Substances

Angiogenesis Inhibitors
Bevacizumab